Literature DB >> 24985046

Ceftriaxone pretreatment protects rats against cerebral ischemic injury by attenuating microglial activation-induced IL-1β expression.

Yang Lujia1, Li Xin, Wang Shiquan, Chen Yu, Zhang Shuzhuo, Zhang Hong.   

Abstract

BACKGROUND: Although the neuroprotective effect of ceftriaxone (CTX) has been reported, the underlying mechanisms are still uncertain. In this study, we investigated if rats recover better from CTX pretreatment against cerebral ischemia by inhibiting the inflammatory response.
METHODS: Rats were pretreated with CTX (200 mg/kg, 1/day, i.p.) for 5 d. At 24 h after the end of the last CTX pretreatment, focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) for 120 min in male Sprague Dawley rats. The neurological deficit scores (NDS) and infarct volumes were evaluated. Microglia cells were observed by immunofluorescence staining and IL-1β was assayed by ELISA and Western Blot.
RESULTS: The results showed that CTX pretreatment improved the neurological deficit scores and decreased the infarct volumes 24 h after reperfusion. The activation of microglia cells was reduced and the expression of IL-1β was partially inhibited 24 h after reperfusion.
CONCLUSION: These findings demonstrate that CTX pretreatment may provide a neuroprotective effect against transient cerebral ischemic injury, partially inhibit in microglial activation and reduce the expression of IL-1β.

Entities:  

Keywords:  ceftriaxone; cerebral ischemia; interleukin-1β; microglia; pretreatment

Mesh:

Substances:

Year:  2014        PMID: 24985046     DOI: 10.3109/00207454.2013.856009

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  7 in total

1.  Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Neuroinflammatory Responses through the Inhibition of TLR4 and CD14 Expression and NF-κB and NLRP3 Inflammasome Activation.

Authors:  Yicong Wei; Jianxiong Chen; Yonghong Hu; Wei Lu; Xiaoqin Zhang; Ruiguo Wang; Kedan Chu
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 2.  Glial and neuroinflammatory targets for treating substance use disorders.

Authors:  Ryan K Bachtell; Jermaine D Jones; Keith G Heinzerling; Patrick M Beardsley; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

Review 3.  The Efficacy of Prophylactic Antibiotics on Post-Stroke Infections: An Updated Systematic Review and Meta-Analysis.

Authors:  Liang Liu; Xiao-Yi Xiong; Qin Zhang; Xiao-Tang Fan; Qing-Wu Yang
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

4.  Gastrodin ameliorates subacute phase cerebral ischemia‑reperfusion injury by inhibiting inflammation and apoptosis in rats.

Authors:  Bo Liu; Fei Li; Jingshan Shi; Danli Yang; Yuanyuan Deng; Qihai Gong
Journal:  Mol Med Rep       Date:  2016-09-26       Impact factor: 2.952

5.  Low-dose minocycline mediated neuroprotection on retinal ischemia-reperfusion injury of mice.

Authors:  Ruojing Huang; Shaomin Liang; Lyujie Fang; Min Wu; Huanhuan Cheng; Xuesong Mi; Yong Ding
Journal:  Mol Vis       Date:  2018-05-18       Impact factor: 2.367

Review 6.  The Role of the Microbiota-Gut-Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases.

Authors:  Mark Obrenovich; Hayden Jaworski; Tara Tadimalla; Adil Mistry; Lorraine Sykes; George Perry; Robert A Bonomo
Journal:  Microorganisms       Date:  2020-05-23

7.  Effects of Ceftriaxone on Oxidative Stress and Inflammation in a Rat Model of Chronic Cerebral Hypoperfusion.

Authors:  Apsorn Sattayakhom; Kosin Kalarat; Thatdao Rakmak; Sompol Tapechum; Arnaud Monteil; Chuchard Punsawad; Sarawoot Palipoch; Phanit Koomhin
Journal:  Behav Sci (Basel)       Date:  2022-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.